COMMUNIQUÉS West-GlobeNewswire

Spark Therapeutics Presents Three Post-hoc Analyses from Phase 3 Clinical Trial of LUXTURNA® (voretigene neparvovec-rzyl) at American Academy of Ophthalmology Annual Meeting
29/10/2018
Use of different measurement for best-corrected visual acuity of participants in the Phase 3 clinical trial of LUXTURNA achieved statistically significant improvement versus control group Mutation subtype analysis [...]
Genmab Announces Positive Topline Results in Phase III MAIA Study of Daratumumab in Front Line Multiple Myeloma
29/10/2018
Company Announcement Phase III MAIA study of daratumumab in combination with lenalidomide and dexamethasone in front line multiple myeloma met the primary endpoint (PFS) at a pre-planned interim analysis demonstrating [...]
MPX Expands Maryland Footprint With Opening of Health for Life White Marsh Dispensary
29/10/2018
TORONTO, Oct. 29, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE: MPX; OTC: MPXEF) announced that the Company will open a new Health for Life dispensary in Nottingham, Maryland [...]
Micron Solutions, Inc. Announces Changes to Executive Management and the Board of Directors
29/10/2018
FITCHBURG, Mass., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American: MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products, [...]
Intellia Therapeutics Names Glenn Goddard as New Chief Financial Officer
29/10/2018
CAMBRIDGE, Mass., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and [...]
VistaGen Therapeutics Reports Fiscal 2019 Second Quarter Financial Results
29/10/2018
SOUTH SAN FRANCISCO, Calif., Oct. 29, 2018 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for central nervous system (CNS) [...]
Alder BioPharmaceuticals® to Host Conference Call to Discuss Third Quarter 2018 Financial and Operating Results
29/10/2018
BOTHELL, Wash., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Assertio Therapeutics Announces the Appointment of Daniel A. Peisert as Senior Vice President and Chief Financial Officer; Current CFO Phil B. Donenberg to Retire November 30, 2018
29/10/2018
LAKE FOREST, Ill., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that Phillip B. Donenberg, Senior Vice President and Chief Financial Officer, will retire effective [...]
Pain Therapeutics Reports Third Quarter 2018 Financial Results
29/10/2018
- Phase IIa Study Initiation On-track for Q4 2018 - AUSTIN, Texas, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a biopharmaceutical company, today reported financial results for the third [...]
GenMark Diagnostics Reports Third Quarter 2018 Results
29/10/2018
CARLSBAD, Calif., Oct. 29, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the [...]
Aclaris Therapeutics to Announce Third Quarter 2018 Financial Results on November 6, 2018
29/10/2018
WAYNE, Pa., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to [...]
Nuvectra® Reports Third Quarter 2018 Financial Results
29/10/2018
Reports Record Algovita ® Sales of $12.5 million, Up 98% YoY PLANO, Texas, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial [...]
AxoGen, Inc. Reports 2018 Third Quarter Financial Results
29/10/2018
Q3 Revenue of $22.7 million, representing 41% growth over prior year; Management reiterates full year 2018 guidance and introduces 2019 guidance ALACHUA, Fla., Oct. 29, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: [...]
Clementia Announces Proposed Public Offering of Common Shares
29/10/2018
MONTREAL, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq: CMTA), a clinical-stage biopharmaceutical company innovating treatments for people with ultra-rare bone disorders and other diseases, [...]
Clementia annonce un projet d’émission publique d’actions ordinaires
29/10/2018
MONTRÉAL, 29 oct. 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ : CMTA), une société biopharmaceutique au stade clinique proposant des traitements novateurs pour les personnes atteintes de troubles [...]
Avance® Nerve Graft Receives Regenerative Medicine Advanced Therapy (RMAT) Designation
29/10/2018
RMAT Designation reinforces clinical significance of RANGER® registry data and acknowledges the unmet need for improved nerve repair solutions ALACHUA, Fla., Oct. 29, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN [...]
Alzheimer’s Foundation of America Encourages Individuals to Get a Free Memory Screening This November During Alzheimer’s Awareness Month
29/10/2018
NEW YORK, Oct. 29, 2018 (GLOBE NEWSWIRE) -- The Alzheimer’s Foundation of America (AFA) is encouraging individuals to be proactive about their brain health and wellness by getting a free, confidential memory screening [...]
BioSig Technologies to Present at the 4th Annual Dawson James Small Cap Growth Conference
29/10/2018
Santa Monica, CA, Oct. 29, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical device company developing a proprietary biomedical signal processing platform designed [...]
Medifirst Solutions Announces New Division for CBD Products
29/10/2018
Freehold, NJ, Oct. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared [...]

Pages